REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 70 filers reported holding REGULUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 3.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $55,000 | -77.8% | 282,186 | -24.9% | 0.00% | – |
Q2 2018 | $248,000 | -10.1% | 375,972 | -2.2% | 0.00% | – |
Q1 2018 | $276,000 | -32.2% | 384,538 | -1.9% | 0.00% | – |
Q4 2017 | $407,000 | -33.8% | 392,142 | -20.3% | 0.00% | – |
Q3 2017 | $615,000 | -10.6% | 492,191 | -29.5% | 0.00% | – |
Q2 2017 | $688,000 | -46.7% | 698,390 | -10.7% | 0.00% | – |
Q1 2017 | $1,291,000 | -16.7% | 782,380 | +13.5% | 0.00% | -100.0% |
Q4 2016 | $1,550,000 | -25.5% | 689,085 | +9.3% | 0.00% | 0.0% |
Q3 2016 | $2,081,000 | +41.0% | 630,332 | +23.4% | 0.00% | 0.0% |
Q2 2016 | $1,476,000 | -47.8% | 510,664 | +25.2% | 0.00% | 0.0% |
Q1 2016 | $2,826,000 | +18.8% | 407,724 | +49.5% | 0.00% | 0.0% |
Q4 2015 | $2,378,000 | +37.7% | 272,652 | +3.3% | 0.00% | 0.0% |
Q3 2015 | $1,727,000 | -37.0% | 264,037 | +5.5% | 0.00% | 0.0% |
Q2 2015 | $2,742,000 | -55.7% | 250,188 | -31.5% | 0.00% | 0.0% |
Q1 2015 | $6,188,000 | +123.9% | 365,378 | +112.0% | 0.00% | 0.0% |
Q4 2014 | $2,764,000 | +116.1% | 172,345 | -8.0% | 0.00% | 0.0% |
Q3 2014 | $1,279,000 | -23.6% | 187,277 | -9.9% | 0.00% | 0.0% |
Q2 2014 | $1,673,000 | +11.0% | 207,970 | +24.5% | 0.00% | 0.0% |
Q1 2014 | $1,507,000 | +70.3% | 167,015 | +39.4% | 0.00% | – |
Q4 2013 | $885,000 | +5.1% | 119,768 | +34.1% | 0.00% | – |
Q3 2013 | $842,000 | +90.5% | 89,331 | +98.5% | 0.00% | – |
Q2 2013 | $442,000 | – | 45,014 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |